- Establish ICPerMed members as global leaders in personalised medicine research,
- Support the personalised medicine science base through a coordinated approach to research,
- Support research to investigate the benefits of personalised medicine to citizens and healthcare systems,
- Pave the way for personalised medicine approaches for citizens.
A retrospective analysis includes statements of ICPerMed’s former vice-chair Wolfgang Ballensiefen and of the five ICPerMed Action Item Groups that paved the way for five new working groups with distinct topics related to personalised medicine: clinical studies, healthcare, patient involvement, education and curricula and health economic values. Ejner Moltzen (ICPerMed chair since summer 2020) provides a vision of ICPerMed’s future activities, also in the view of the new European Commission Framework Programme “Horizon Europe”.
For its ambitious work, ICPerMed received direct support from the European Commission in the form of a “second edition” of the ICPerMed Secretariat (2021-2023) and additional support in the form of eight coordination and support actions (CSA) funded around the international consortium, strengthening with their dedicated PM focus ICPerMed’s progress and contributing substantially to its success. These CSAs are presented in this report together with ICPerMed’s longstanding partner programme: the ERA-Net, ERA PerMed.
We report how ICPerMed reflected in 2020 on building a sustainable PM framework to foster strategic reflections and funding opportunities in personalised medicine in the view
of Horizon Europe: A Joint Sustainability Workshop organised together with ERA PerMed and a draft concept paper developed that is outlining ICPerMed’s and ERA PerMed’s view on the need for and potential of a future European Partnership for Personalised Medicine.